EP
AMGN icon

Essential Partners’s Amgen AMGN Stock Holding History

Essential Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
50
+38
+317% +$13K 0.01% 945
2026
Q1 		$4.27K Buy
12
+2
+20% +$713 ﹤0.01% 1656
2025
Q4 		$3.31K Buy
10
+2
+25% +$634 ﹤0.01% 1603
2025
Q3 		$2.29K Sell
8
-12
-60% -$3.48K ﹤0.01% 1751
2025
Q2 		$5.58K Buy
+20
New +$5.67K ﹤0.01% 1020

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Essential Partners's AMGN Position: Q2 2026 in Review

Essential Partners increased its Amgen (AMGN) stake by 317% in Q2 2026, buying an estimated $13K and bringing the position to 50 shares worth $18.1K. The position accounts for 0.01% of the portfolio, ranked #945.

Essential Partners first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Essential Partners held 50 shares of Amgen worth $18.1K as of Q2 2026.
  • Essential Partners bought 38 Amgen shares in Q2 2026, an estimated $13K.
  • Amgen made up 0.01% of Essential Partners's portfolio in Q2 2026, its #945 holding.
  • Essential Partners first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.